Strategies To Reduce HIV Treatment Dropout Rates: Cost-Effective And Improve Survival Chances
Posted on: Tuesday, 27 October 2009, 12:03 CDT
Press release from PLoS Medicine
In a study published this week in PLoS Medicine, Elena Losina (of Massachusetts General Hospital, Boston) and colleagues predict that strategies to reduce dropout rates from HIV treatment programs in resource-poor settings would substantially improve patients' chances of survival and would be cost-effective. Combining a computer simulation model with data from a program of antiretroviral delivery in Abidjan, Cote d'Ivoire, the researchers assessed the potential benefits of several interventions, including reducing the cost to patients of getting treatment (by eliminating co-payments for treatment and by paying for transport) and increasing the services available to patients at their visits to clinics (such as improving staff training in HIV care, and providing meals at clinic times). The researchers conclude that these strategies to reduce dropout rates from HIV treatment should form part of the commitment to start antiret roviral treatment and treat HIV in resource-poor settings.
In a related Perspective, Gregory Bisson (of the University of Pennsylvania School of Medicine) and Jeffrey Stringer (of the University of Alabama School of Medicine), both uninvolved with the research, agree that improving retention in HIV/AIDS care makes programmatic and economic sense. They stress that "the major AIDS donors, such as the US President's Emergency Plan For AIDS Relief (PEPFAR) and the Global Fund, should be keenly interested in this issue, and willing to invest in strategies to improve retention.''
---
On the Net:
Related Articles
- No Disparities by Race/Ethnicity in Risk of AIDS and Death Among HIV-Infected Patients in Kaiser Permanente's Integrated Delivery System, Research Study Finds
- American Academy of HIV Medicine Streamlines Delivery of Critical News and Information to Its Members and HIV Specialists Through ActiveAccess Desktop Application
- GlaxoSmithKline Sponsors HIV Medicine Association Minority Fellowship Program
- Diagnostic Utility of Bone Marrow Sampling in HIV-Infected Patients Since the Advent of Highly Active Antiretroviral Therapy
- Koronis Pharmaceuticals Begins Phase 1b Clinical Trial of Novel Anti-Viral HIV/AIDS Therapeutic in HIV-Positive Patients
- Effects of bacterial pneumonia no worse for HIV-positive patients
- Experts Say Integration of Chinese, Western Medicine to Prolong AIDS Patients' Lives
- New Planning Tool Streamlines Brachytherapy Treatments and Improves Patient Comfort
- Risk Factors for Myocardial Infarction in HIV-Positive Patients
- Metabolic Syndrome Among HIV-Infected Patients: Prevalence, Characteristics, and Related Factors
 |
 |
User Comments (0)
RSS Feeds